BRSR for F.Y. 2025-26

MedPlus Health Services Limited July 23, 2026 The Listing Department The Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra Kurla Complex, Dalal Street, Fort, Mumbai 400 001 Bandra (East), Mumbai – 400 051 Scrip Code: 543427 Symbol: MEDPLUS Dear Sir/Madam, Subject: Business Responsibility and Sustainability Report for the Financial Year 2025-26. Pursuant to Regulation 34(2)(f) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith the Business Responsibility and Sustainability Report of the Company for the Financial Year 2025-26, which also forms part of the Annual Report of the Company for the Financial Year 2025-26. The same will be available on the website of the Company at www.medplusindia.com and also on the websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com respectively. You are requested to kindly take note of the same. Thanking You Yours faithfully For MedPlus Health Services Limited Shrenik Soni Company Secretary & Compliance Officer (M. No. F12400) Enclosed: a/a 040-6724 6724 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com Annexure II (Business Responsibility and Sustainability Reporting (BRSR) is the practice of companies disclosing information about their as environmental impact, social responsibility, and governance practices, aiming to promote transparency and accountability.) SECTION A: GENERAL DISCLOSURES 1. Details of the listed entity Particulars 1 Corporate Identity Number (CIN) of the Listed Entity 2 Name of the Listed Entity MedPlus Health Services Limited 3 Year of incorporation 30/11/2006 Railway Siding Road, Moosapet, Kukatpally Hyderabad TG 500037 INRailway Siding Road, Moosapet, Kukatpally Hyderabad, TG 500037 IN 5 Corporate address Railway Siding Road, Moosapet, Kukatpally Hyderabad TG 500037 INRailway Siding Road, Moosapet, Kukatpally Hyderabad, TG 500037 IN 6 E-mail cs@medplusindia.com 7 Telephone 040-62746274 Website http://www.medplusindia.com/ 9 1st April 2025 to 31st March 2026 10 Name of the Stock Exchange(s) where shares are listed National Stock Exchange of India Ltd 11 Paid-up Capital 240.11 million 12 Name and contact details (telephone, email address) of the Manoj Kumar Srivastava manoj.srivastava@medplusindia.com BRSR report 040 -62746274 13 Reporting boundary - Are the disclosures under this report Standalone basis* made on a standalone basis (i.e. only for the entity) or on a consolidated basis (i.e. for the entity and all the entities taken together) 14 Name of assurance provider NA 15 Type of assurance obtained NA *MedPlus Health Services Limited (MHSL’ or ‘MedPlus), being a retail pharmacy Company, has various retail outlets and other operations under Optival Health Solutions Private Limited (OHSPL or Optival). As ~ 90% of the operations are carried out through OHSPL, it has been included in the reporting boundary. 16. Details of business activities (accounting for 90% of the turnover): Sr. % of Turnover of Description of Main Activity Description of Business Activity No. the entity 1 Hospital and Medical Care Pharmaceutical products, Medical and orthopedic goods 2 Hospital and Medical Care 1.90% Sr. % of total Turnover NIC Code No. Contributed 1 Retail Trade services: Pharmaceutical products, Medical and orthopedic goods 47721 2 1.90% III. Operations Location Number of plants Total National 5 5709 5714 International 0 0 0 19.Markets served by the entity: a. Number of locations Locations Number National (No. of States) 14 International (No. of Countries) 0 b. What is the contribution of exports as a percentage of the total turnover of the entity? 0 c. A brief on types of customers As one of India’s largest retail pharmacy chains, MedPlus serves enduse consumers of pharmaceutical and fastmoving consumer Pharmaceutical and wellness items- prescription medicines, overthecounter drugs, vitamins, medical devices, and diagnostic test kits. and sanitizers. IV. Employees 20. Details as at the end of Financial Year: Sr. Total Male Female Particulars No. (A) No. (B) No. (C) EMPLOYEES 1 27,686 31.76% 2 Other than Permanent (E) NA NA NA NA NA 3 Total employees (D + E) 27,686 31.76% WORKERS 4 NA NA NA NA NA 5 Other than Permanent (G) NA NA NA NA NA 6 Total workers (F + G) NA NA NA NA NA Sr. Total Male Female Particulars No. (A) No. (B) No. (C) DIFFERENTLY ABLED EMPLOYEES 1 0 0 0% 0 0% 2 Other than Permanent (E) 0 0 0% 0 0% 3 0 0 0% 0 0% DIFFERENTLY ABLED WORKERS 4 NA NA NA NA NA 5 Other than Permanent (E) NA NA NA NA NA 6 NA NA NA NA NA therefore, not applicable. Total No. and percentage of Females (A) No. (B) 6 1 16.67% Key Management Personnel 4 0 0% Turnover rate for permanent employees and workers (Turnover rate in (Turnover rate in (Turnover rate in the year Particular current FY) previous FY) prior to the previous FY) Male Total Male Female Total Male Female Total Permanent Employees 42.29% 42.95% 42.50% 40.56% 45.47% 42.09% 45.39% 45.69% Permanent Workers NA NA NA NA NA NA NA NA NA V. Holding, Subsidiary and Associate Companies (including joint ventures) Indicate whether Does the entity indicated % of shares at column A, participate in held by the Business responsibility listed entity initiatives of the listed Venture 1 Optival Health Solutions Private Limited (OHSPL) 99.99% Yes 2 Wynclark Pharmaceuticals Private Limited (WPPL) 100% No 3 Nova Sud Pharmaceuticals Private Limited (NPPL) 100% No 4 Sai Sridhar Pharma Private Limited (SSPPL) 100% No 5 Venkata Krishna Enterprises Private Limited (VKEPL) 100% No Subsidiary 6 100% No Company 7 Shri Banashankari Pharma Private Limited (SBPPL) 100% No 100% No 9 Kalyani Meditimes Private Limited (KMT) No 10 Clearancekart Private Limited 100% No 11 MedPlus Insurance Brokers Private Limited (MIBPL) 100% No V. CSR Details a. Turnover (in Million) b. Net worth (in Million) 13,161.13 Note: This represents Medplus’s standalone turnover and net worth VI. Transparency and Disclosures Compliances Business Conduct: Current Financial Year Previous Financial Year Grievance Number of Stakeholder group Redressal Number of Number of Number of complaints from whom complaint Mechanism complaints complaints is received in Place pending Remarks complaints pending Remarks resolution at resolution at during the year close of the the year close of the year year Communities Yes 0 0 - 0 0 - Investors (other than Yes 0 0 - 0 0 - shareholders) Shareholders Yes 0 0 - 0 0 - Employees and Yes 56 0 - 0 0 - workers* Customers Yes 0 - 0 - Value Chain Partners Yes 0 0 - 0 0 - Other (please specify) Yes 0 0 - 0 0 - * Grievance Redressal Mechanism in Place (Yes/No) (If Yes, then provide web-link for grievance redress policy) Stakeholder group from whom Web Link for Grievance Policy complaint is received Communities Investors (other than shareholders) MedPlus publishes its policies on the Company’s website under the ‘Investors’ section, Shareholders accessible through the Corporate Governance page: Employees and workers https://www.medplusindia.com/corporate.jsp. Customers Additionally, several internal policies are available to employees through the Value Chain Partners Company’s intranet Other (please specify) Please indicate material responsible business conduct and sustainability issues pertaining to environmental and social matters that present a risk or an opportunity to your business, rationale for identifying the same, approach to adapt or mitigate the risk Financial Indicate implications of the Material whether Sr. Rationale for identifying In case of risk, approach risk or opportunity issue risk or No. to adapt or mitigate (Indicate positive opportunity or negative implications) 1 Patient O MedPlus, a lea [Showing first 8,000 characters — download PDF for full document]